Twist Bioscience Corp. (TWST)

132.06 -6.94 (-4.99%) USD  |  NASDAQ  |  Sep 01, 16:00
132.01 -0.05 (-0.04%) Pre-Market: 08:59
More

Twist Bioscience Research and Development Expense (Annual) : 80.28M for Sept. 30, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for TWST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2025 80.28M
September 30, 2024 90.85M
September 30, 2023 106.89M
September 30, 2022 120.31M
September 30, 2021 69.07M
Date Value
September 30, 2020 43.01M
September 30, 2019 35.68M
September 30, 2018 20.35M
September 30, 2017 19.17M
September 30, 2016 18.23M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Beam Therapeutics, Inc. 409.62M
Intellia Therapeutics, Inc. 379.09M
Prime Medicine, Inc. 160.64M
Absci Corp. 80.72M
10X Genomics, Inc. 238.63M